Skip to main content
SpringerLink
Log in

Metabolism of ether phospholipids and analogs in neoplastic cells

  • Published:
Lipids

Abstract

The ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (OM-GPC) is known to be a potent inhibitor of cell growth. Metabolic studies in both Raji and L1210 leukemic cells on OM-GPC,3H-labeled in the methyl groups of the choline moiety, showed a (diacyl)-phosphatidylcholine as the only labeled metabolite. Since the formation of radiolabeled (diacyl)-phosphatidylcholine showed a direct correlation with cell death, we tested other lipid analogs. One of these compounds, hexadecylphosphocholine (He-PC), which was3H-labeled in the methyl-choline groups, showed a formation of labaled (diacyl)-phosphatidylcholine similar to that found with OM-GPC. Again, there was a direct linear correlation between the formation of the labeled product and cell death. He-PC was found to be a potent cell toxin in in vitro experiments on cell cultures. However, analogs with an elongated phosphor to trimethylammonium distance showed no toxicity towards the cells in in vitro experiments. From the data, we conclude that the ether phospholipids are substrates for a phospholipase C or related enzyme. This substrate property may be responsible for the toxicity of the compounds in neoplastic cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

OM-GPC:

1-O-octadecyl-2-O-methyl-rac-glycero-3-hoshocholine

OM-G:

1-O-octadecyl-2-O-methyl-rac-glycerol

He-PC:

hexadecylphosphocholine

Ol-PC:

octadecenyl(9,10)phosphocholine

Ol-P(C6)C:

octadeceny(9, 10)phospho-(N,N,N-trimethylamino)hexanol

References

  1. Berdel, W.E., schick, H.D., Fink, U., Reichert, A., Ulm, K., and Rastetter, J. (1985)Cancer Res. 45, 1206–1213.

    PubMed  CAS  Google Scholar 

  2. Tidwell, T., Guzman, G., and Vogler, W.R. (1981)Blood 57, 794–797.

    PubMed  CAS  Google Scholar 

  3. Helfman, D.M., Barnes, K.C., Kinkade, J.M. Jr., Vogler, W.R., Shoji, M., and Kuo, J.F. (1983)Cancer Res. 43, 2955–2961.

    PubMed  CAS  Google Scholar 

  4. Berdel, W.E., Greiner, E., Fink, U., Zänker, K.S., Stavrou, D., Trappe, A., Fahlbusch, R., Reichelt, A., and Rastetter, J. (1984)Oncology 41, 140–145.

    Article  PubMed  CAS  Google Scholar 

  5. Storme, G.A., Berdel, W.E., van Blitterswijk, W.J., Buyneel, E.A., De Bruine, G.K., and Mareel, M.M. (1985)Cancer Res. 45, 351–357.

    PubMed  CAS  Google Scholar 

  6. Munder, P.G., Modolell, M., Bausert, W., Oettgen, H.F., and Westphal, O. (1981) inAugmenting Agents in Cancer Therapy (Hersch, E.M., Chirgos, M.A., and Mastrangelo, M.J., eds.) pp. 441–458, Raven Press, New York, NY.

    Google Scholar 

  7. Berdel, W.E. (1982)Blutt 44, 71–78.

    Article  CAS  Google Scholar 

  8. Munder, P.G. (1973)Biochemische und biologische Untersuchungen zum Wirkmechanismus von Adjuvantien (Habilitationsschrift) Universität Freiburg, Freiburg, FRG.

    Google Scholar 

  9. Soodsma, J.F., Piantadosi, C., and Snyder, F.J. (1972)J. Biol. Chem. 247, 3923–3929.

    PubMed  CAS  Google Scholar 

  10. Unger, C., Eibl, H., von Heyden, H.-W., and Nagel, G.A. (1985)Cancer Res. 45, 616–618.

    PubMed  CAS  Google Scholar 

  11. Lee, T.C., Blank, M.L., Fitzgerald, V., and Snyder, F. (1981)Arch. Biochem. Biophys. 208, 353–357.

    Article  PubMed  CAS  Google Scholar 

  12. Kötting, J. (1986)O-Alkyl Spaltende Enzyme in Lebergewebe, Ph.D. Thesis, p. 129, Technical University Carolo-Wilhelmina, Braunschweig, FRG.

    Google Scholar 

  13. Unger, C., Eibl, H., Kim, D.-J., Fleer, E.A.M., Bartsch, H.H., Nagel, G.A., and Pfitzenmaier, K. (1987)J.N.C.I. 78, 219–222.

    CAS  Google Scholar 

  14. Eibl, H. (1984)Angew. Chemie 23, 257–271.

    Article  Google Scholar 

  15. Eibl, H., and Westphal, O. (1967)Liebigs Ann. Chem. 709, 231–233.

    CAS  Google Scholar 

  16. Eibl, H., and Woolley, P. (1986)Chem. Phys. Lipids 41, 53–63.

    Article  CAS  Google Scholar 

  17. Fleer E.A.M., Kim, D.-J., Unger, C., and Eibl, H. inSynthesis and Application of Isotopically Labeled Compounds, Proceedings of the Second International Symposium, Kansas City, MO, September 3–6 (1985) (Muccino, R.R., ed.), pp. 473–478, Elsevier, Amsterdam.

  18. Hudson, L., and Hay, F.C. (1976)Practical Immunology, pp. 29–32, Blackwell Scientific Publications, Oxford, England.

    Google Scholar 

  19. Bligh, E.G., and Dyer, W.J. (1959)Can. J. Physiol. 37, 911–917.

    Article  CAS  Google Scholar 

  20. Diembeck, W., and Eibl, H. (1979)Chem. Phys. Lipids 24, 237–244.

    Article  CAS  Google Scholar 

  21. Unger, C., and Eibl, H. (1986) inMammakarziome—Neue Perspektiven experimenteller und klinischer Therapieforschung (Nagel, G.A., ed.) pp. 115–123, Springer-Verlag, Berlin, Heidelberg, FRG.

    Google Scholar 

  22. Voelker, D.R., and Kennedy, E. (1983)Methods Enzymol. 98, 596–598.

    Article  PubMed  CAS  Google Scholar 

  23. Eibl, H., and Unger, C. (1986) inMammakarzinome—Phospholipide als Antitumormittel—Eine neues Konzept (Nagel, G.A., ed.) pp. 124–132, Springer-Verlag, Berlin, Heidelberg, FRG.

    Google Scholar 

  24. Eibl, H., and Unger, C. (1985) inDie Zellmembran als Angriffs punkt der Tumortherapie-Phospholipide als Antitumormittel: Möglichkeiten einer selekfiven Therapie (Unger, C., Eibl, H., and Nagel, G.A., eds.) pp. 1–18, Zuckschwerdt Verlag, München, Bern, Wien, San Francisco.

    Google Scholar 

  25. Van Blitterswijk, W.J., van der Bend, R.L., Hilkman, H., and de Widt, J. (1987)Lipids 22, 842–846.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Max-Planck-Institut für biophysikalische Chemie, Abt. 140, Am Fassberg, D 3400, Goettingen, West Germany

    E. A. M. Fleer, D. -J. Kim & H. Eibl

  2. Department of Heamatology/Oncology, Klinikum der Universität Goettingen, Robert-Koch-Str. 40, D 3400, Goettingen, West Germany

    C. Unger

Authors
  1. E. A. M. Fleer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Unger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. -J. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Eibl
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Fleer, E.A.M., Unger, C., Kim, D.J. et al. Metabolism of ether phospholipids and analogs in neoplastic cells. Lipids 22, 856–861 (1987). https://doi.org/10.1007/BF02535544

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02535544

Keywords

Search

Navigation